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During the time period 1975 -2004, 22 759 white patients were diagnosed with esophageal cancer (16 493 men and 6266 women), of whom 9526 were diagnosed with adenocarcinoma (8128 men and 1398 women). Among white men, total ageadjusted esophageal cancer rates increased steadily from 5.76 per 100 000 personyears (95% CI = 5.49 to 6.03) during 1975 -1979 Total esophageal cancer incidence and mortality have been increasing among white men, stable among white women, and decreasing in black men and women ( 1 ) . It is projected that there will be 16 470 new patients diagnosed with esophageal cancer and 14 280 deaths from it in 2008 ( 2 ). Rapid increases in the incidence of adenocarcinoma of the esophagus have been reported in the United States, with rates highest among white males ( 3 -6 ) . These patterns are in contrast to those for squamous cell carcinoma of the esophagus, for which rates have been considerably higher among blacks than whites and have been declining in recent decades. To better understand the temporal patterns and to assess the potential influence of heightened surveillance for adenocarcinoma we performed a detailed examination of the temporal trends among white individuals by sex, stage, and age. Esophageal adenocarcinoma cases among blacks (211) and other races (185) were too few for in-depth analyses.
Data from nine population-based registries in the National Cancer Institute ' s Surveillance, Epidemiology, and End Results (SEER) program ( 1 ) were used to calculate incidence rates of primary invasive esophageal cancer ( International Classifi cation of Diseases for Oncology , 3rd edition, topography codes 150 -159) for 22 759 white ( 7 ) . The nine registries, accounting for approximately 10% of the US population, are located in the metropolitan areas of Atlanta, Detroit, San Francisco -Oakland, and Seattle -Puget Sound and the states of Connecticut, Hawaii, Iowa, New Mexico, and Utah. All SEER Registries annually meet the Gold Standard Registry Certifi cation from the North American Association of Central Cancer Registries, Inc, for completeness (at least 95%), accuracy (<3% of cases identifi ed through death certifi cates only), and timeliness of data. Age-adjusted rates (using the 2000 US standard) and 95% confi dence intervals (CIs) were calculated by sex and histological type (adenocarcinoma, morphology codes 8140 -8575; squamous cell carcinoma, codes 8050 -8084) by use of SEER*Stat software ( 8 ) . Age-adjusted rates by stage (local, regional, distant, and unknown, as indicated by SEER historic stage A) and age-specifi c rates (age groups 25 -44, 45 -54, 55 -64, 65 -74, and ≥ 75 years) were calculated for adenocarcinoma by sex. All rates were expressed per 100 000 person-years, and only data points with at least 10 observations were presented. Temporal trends Over the three decades studied, the increases in adenocarcinoma occurred across all age groups. Among men, the greatest rates of increase (about 600%) and the highest rates were observed for the two oldest age groups, those aged 65 years or older. Rates also increased across all age groups among women, and the slopes appear remarkably parallel.
This study has several limitations. Cases of adenocarcinoma of the esophagus may have been missed or misclassifi ed, but this is unlikely because quality control efforts regarding case fi nding, abstracting, and coding have been an integral part of the SEER program since its inception ( 1 ) . Data for the most recent years may be underreported, and SEER has estimated delay-adjusted rates in many instances. Thus, the upward trends in adenocarcinoma may be even more pronounced than what we have reported. The pathological diagnoses were not reviewed centrally, but the microscopic distinction between adenocarcinoma and squamous cell carcinoma has been recognized for decades. Furthermore, declines in the histological type category
CONTEXT AND CAVEATS

Prior knowledge
Rapid increases in the incidence of adenocarcinoma of the esophagus have been reported among white men.
Study design
Registry study in which data from the Surveillance, Epidemiology, and End Results program from January 1, 1975, through December 31, 2004, was used to explore the temporal patterns of this disease among white individuals by sex, stage, and age. A similar rapid increase was also apparent among white women, with an increased incidence of 335% from 0.17 per 100 000 person-years to 0.74 per 100 000 person-years.
Contribution
Implications
Because the increases in incidence are independent of stage and age group, they appear to be real and not an artifact of surveillance.
Limitations
Cases of adenocarcinoma may have been missed or misclassified. Data for the most recent years may have been underreported. Pathological diagnoses were not reviewed centrally. other and not otherwise specifi ed that might indicate improving specifi city of the diagnoses were modest and could not explain the observed increases in adenocarcinoma. Adenocarcinoma rates are rising rapidly and at a similar pace among both white men and women. This increase was not clear in earlier reports ( 3 -6 ) because of the rarity of adenocarcinoma among women. Improving diagnosis or increasing exposures may be affecting both sexes. All rates by stage rose at similar paces; however, the rate of increase may be slowing, especially for localized disease, indicating that the overall increase in adenocarcinoma incidence is unlikely to refl ect heightened surveillance and earlier diagnosis. The increases appeared across all age groups, and the slopes were remarkably similar to each other. The parallel upward trends by age groups make it diffi cult to determine whether the patterns are refl ecting only period effects, as observed for prostate cancer and prostate-specifi c antigen screening ( 10 ), or whether birth cohort effects may play a role, as observed convincingly for lung cancer and cigarette smoking ( 11 , 12 ). An earlier analysis that developed multistage carcinogenesis models by use of 1973 -2000 SEER data indicated that the adenocarcinoma temporal trends were driven more by period than birth cohort effects ( 13 ) .
From the Editors
Our fi ndings are consistent with a Dutch study ( 14 ) that reported a substantial increase in Barrett esophagus, the precursor lesion for adenocarcinoma, that was not explained by changes in endoscopic practice or histopathological criteria. Although the exact mechanism is unclear, Barrett esophagus may be related to the higher intraabdominal pressure and increased prevalence of gastroesophageal refl ux disease in obese individuals. We previously presented ( 6 ) data showing rapid increases in refl ux disease among US veterans, with rates of increase that were similar to those for adenocarcinoma. Also, increases in obesity by age and sex since the mid-1970s appear to parallel increases in adenocarcinoma ( 15 ) , and recent data ( 16 ) indicate that increases in obesity, particularly abdominal obesity, may account for part of the upward trend in the incidence of adenocarcinoma ( 13 , 17 ) . Another reason for the increasing frequency of Barrett esophagus -associated adenocarcinoma may be the decreasing frequency of infection with Helicobacter pylori , which is associated with gastric atrophy and reduction in gastric acid secretion ( 18, 19 ) . Our data indicate that the increase in adenocarcinoma is real
